Tapewire

Nasdaq · USD

OPCH

Option Care Health, Inc.

Export transactions ↓
Tapewire entity
4126
SEC CIK
0001014739
Parsed reports
380

Last 12 months

Inside the activity.

5 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202640
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2026 Filed Feb 20, 2026 00:30 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
GrantCommon Stock 78,876 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004774 · rdgdoc.xml · nonDerivative · entry 1

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 831,057

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 00:30 UTC
Adewunmi FemiChief Medical Officer
GrantCommon Stock 9,579 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004773 · rdgdoc.xml · nonDerivative · entry 1

Adewunmi Femi · CIK 0002020079 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,337

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 00:25 UTC
Sethna MeenalChief Financial Officer
GrantCommon Stock 27,045 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004772 · rdgdoc.xml · nonDerivative · entry 1

Sethna Meenal · CIK 0001643464 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,112

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 00:25 UTC
Smyser CollinGC & Corporate Secretary
GrantCommon Stock 15,213 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004771 · rdgdoc.xml · nonDerivative · entry 1

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,215

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:02 UTC
Whitworth LukeChief Operating Officer
Tax withholdingCommon Stock 508 $35.24 $17,901.92
Disclosure

SEC source: 0001437749-26-004781 · rdgdoc.xml · nonDerivative · entry 1

Whitworth Luke · CIK 0001961976 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,815

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:02 UTC
Grashoff Christopher L.Chief Growth Officer
Tax withholdingCommon Stock 259 $35.24 $9,127.16
Disclosure

SEC source: 0001437749-26-004780 · rdgdoc.xml · nonDerivative · entry 1

Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,880

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:01 UTC
Bavaro MichaelChief Human Resources Officer
Tax withholdingCommon Stock 551 $35.24 $19,417.24
Disclosure

SEC source: 0001437749-26-004779 · rdgdoc.xml · nonDerivative · entry 1

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,423

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:00 UTC
Maggio NicoleChief Accounting Officer
Tax withholdingCommon Stock 247 $35.24 $8,704.28
Disclosure

SEC source: 0001437749-26-004778 · rdgdoc.xml · nonDerivative · entry 1

Maggio Nicole · CIK 0002032392 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,229

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:30 UTC PurchaseCommon Stock 38,000 $25.98 $987,392.00
Disclosure

SEC source: 0001437749-25-033040 · rdgdoc.xml · nonDerivative · entry 1

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,390

F1 · price: Reflects the weighted average price of 38,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on November 3, 2025 with purchase prices ranging from $25.835 to $26.235 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:15 UTC
Sethna MeenalChief Financial Officer
GrantCommon Stock 55,067 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-030477 · rdgdoc.xml · nonDerivative · entry 1

Sethna Meenal · CIK 0001643464 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,067

F1 · shares: The restricted stock units granted in this award vest on the third anniversary of the grant date.

Read SEC document
September 09, 2025 Filed Sep 10, 2025 20:18 UTC PurchaseCommon Stock 3,411 $29.31 $99,976.07
Disclosure

SEC source: 0001437749-25-028768 · rdgdoc.xml · nonDerivative · entry 1

Wright Norman L. · CIK 0001933103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,501

F1 · price: Reflects the weighted average price of 3,411 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on September 9, 2025 with purchase prices ranging from $29.28 to $29.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 21, 2025 Filed Aug 21, 2025 22:24 UTC PurchaseCommon Stock 20,000 $27.51 $550,200.00
Disclosure

SEC source: 0001437749-25-027535 · rdgdoc.xml · nonDerivative · entry 1

SULLIVAN TIMOTHY P · CIK 0001245970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,229

Read SEC document
August 21, 2025 Filed Aug 21, 2025 22:24 UTC PurchaseCommon Stock 1,000 $27.63 $27,625.00
Disclosure

SEC source: 0001437749-25-027534 · rdgdoc.xml · nonDerivative · entry 1

GOLDING DAVID W · CIK 0001286630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,525

Read SEC document
August 20, 2025 Filed Aug 21, 2025 22:26 UTC PurchaseCommon Stock 750 $27.19 $20,391.45
Disclosure

SEC source: 0001437749-25-027538 · rdgdoc.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,910

F1 · price: Reflects the weighted average price of 750 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $27.18 to $27.1899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 20, 2025 Filed Aug 21, 2025 22:25 UTC PurchaseCommon Stock 36,000 $27.15 $977,277.60
Disclosure

SEC source: 0001437749-25-027536 · rdgdoc.xml · nonDerivative · entry 1

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,390

F1 · price: Reflects the weighted average price of 36,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $26.92 to $27.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 06, 2025 Filed Aug 8, 2025 20:23 UTC
Maggio NicoleChief Accounting Officer
GrantCommon Stock 7,167 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-025729 · rdgdoc.xml · nonDerivative · entry 1

Maggio Nicole · CIK 0002032392 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,476

F1 · shares: The restricted stock units granted in this award vest in full on August 6, 2027.

Read SEC document
May 19, 2025 Filed May 21, 2025 20:17 UTC
Smyser CollinGC & Corporate Secretary
Exercise / conversionRestricted Stock Unit · Derivative 10,384 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017987 · rdgdoc.xml · derivative · entry 6

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,384 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F3 · derivative.exercise_date: All restricted stock units granted in this award vested on May 19, 2025.

F3 · derivative.expiration_date: All restricted stock units granted in this award vested on May 19, 2025.

Read SEC document
May 19, 2025 Filed May 21, 2025 20:17 UTC
Smyser CollinGC & Corporate Secretary
Exercise / conversionRestricted Stock Unit · Derivative 812 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017987 · rdgdoc.xml · derivative · entry 5

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 812

Underlying: Common Stock · 812 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F2 · derivative.exercise_date: All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.

F2 · derivative.expiration_date: All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
May 19, 2025 Filed May 21, 2025 20:17 UTC
Smyser CollinGC & Corporate Secretary
Tax withholdingCommon Stock 10,713 $33.09 $354,493.17
Disclosure

SEC source: 0001437749-25-017987 · rdgdoc.xml · nonDerivative · entry 3

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,002

Read SEC document
May 19, 2025 Filed May 21, 2025 20:17 UTC
Smyser CollinGC & Corporate Secretary
Exercise / conversionCommon Stock 10,384 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017987 · rdgdoc.xml · nonDerivative · entry 2

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2025 Filed May 21, 2025 20:17 UTC
Smyser CollinGC & Corporate Secretary
Exercise / conversionCommon Stock 812 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017987 · rdgdoc.xml · nonDerivative · entry 1

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:28 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017676 · rdgdoc.xml · nonDerivative · entry 1

BETTEN ELIZABETH QUADROS · CIK 0001780016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,373

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:28 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017675 · rdgdoc.xml · nonDerivative · entry 1

Bierbower Elizabeth D · CIK 0001561149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,874

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:27 UTC GrantCommon Stock 627 $31.79 $19,932.33
Disclosure

SEC source: 0001437749-25-017674 · rdgdoc.xml · nonDerivative · entry 2

Deckmann Natasha · CIK 0001902330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,161

F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:27 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017674 · rdgdoc.xml · nonDerivative · entry 1

Deckmann Natasha · CIK 0001902330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,534

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:27 UTC GrantCommon Stock 3,381 $31.79 $107,481.99
Disclosure

SEC source: 0001437749-25-017673 · rdgdoc.xml · nonDerivative · entry 2

GOLDING DAVID W · CIK 0001286630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,525

F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:27 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017673 · rdgdoc.xml · nonDerivative · entry 1

GOLDING DAVID W · CIK 0001286630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,144

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:26 UTC GrantCommon Stock 8,022 $31.79 $255,019.38
Disclosure

SEC source: 0001437749-25-017672 · rdgdoc.xml · nonDerivative · entry 2

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,390

F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:26 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017672 · rdgdoc.xml · nonDerivative · entry 1

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,368

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:26 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017671 · rdgdoc.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,160

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:25 UTC GrantCommon Stock 3,381 $31.79 $107,481.99
Disclosure

SEC source: 0001437749-25-017670 · rdgdoc.xml · nonDerivative · entry 2

SULLIVAN TIMOTHY P · CIK 0001245970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,229

F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:25 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017670 · rdgdoc.xml · nonDerivative · entry 1

SULLIVAN TIMOTHY P · CIK 0001245970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,848

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:25 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017669 · rdgdoc.xml · nonDerivative · entry 1

Bodem Barbara W. · CIK 0001713893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,090

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:23 UTC GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017668 · rdgdoc.xml · nonDerivative · entry 1

Wright Norman L. · CIK 0001933103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,090

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
May 14, 2025 Filed May 19, 2025 22:23 UTC
BRANDT ERICDirector
GrantCommon Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-017667 · rdgdoc.xml · nonDerivative · entry 1

BRANDT ERIC · CIK 0001190639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,359

F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025.

Read SEC document
April 22, 2025 Filed Apr 24, 2025 21:01 UTC
Adewunmi FemiChief Medical Officer
Tax withholdingCommon Stock 1,396 $31.54 $44,029.84
Disclosure

SEC source: 0001437749-25-012987 · rdgdoc.xml · nonDerivative · entry 1

Adewunmi Femi · CIK 0002020079 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,758

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,386 $0.00 Strike: $28.86 $0.00
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 9

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,772

Underlying: Common Stock · 2,386 shares

Expires 2033-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Stock options that vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,153 $0.00 Strike: $23.96 $0.00
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 8

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,153

Underlying: Common Stock · 2,153 shares

Expires 2032-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 8,974 $0.00 Strike: $25.75 $0.00
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 7

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,974 shares

Expires 2031-10-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,226 $0.00 Strike: $18.97 $0.00
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 6

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,226 shares

Expires 2031-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
SaleCommon Stock 30,996 $33.26 $1,030,843.27
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 5

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,974

F1 · price: Reflects the weighted average price of 30,996 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 28, 2025 with sale prices ranging from $33.25 to $33.285 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionCommon Stock 2,386 $28.86 $68,859.96
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 4

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,970

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionCommon Stock 2,153 $23.96 $51,585.88
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 3

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionCommon Stock 8,974 $25.75 $231,080.50
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 2

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2025 Filed Mar 3, 2025 22:52 UTC
Bavaro MichaelChief Human Resources Officer
Exercise / conversionCommon Stock 1,226 $18.97 $23,257.22
Disclosure

SEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 1

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 24, 2025 Filed Feb 27, 2025 00:40 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
GrantCommon Stock 74,814 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-005307 · rdgdoc.xml · nonDerivative · entry 1

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 752,181

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 24, 2025 Filed Feb 27, 2025 00:40 UTC
Adewunmi FemiChief Medical Officer
GrantCommon Stock 10,287 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-005306 · rdgdoc.xml · nonDerivative · entry 1

Adewunmi Femi · CIK 0002020079 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,154

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 24, 2025 Filed Feb 27, 2025 00:39 UTC
Bavaro MichaelChief Human Resources Officer
GrantCommon Stock 10,599 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-005305 · rdgdoc.xml · nonDerivative · entry 1

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,231

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 24, 2025 Filed Feb 27, 2025 00:39 UTC
Grashoff Christopher L.Chief Growth Officer
GrantCommon Stock 13,404 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-005304 · rdgdoc.xml · nonDerivative · entry 1

Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,139

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 24, 2025 Filed Feb 27, 2025 00:38 UTC
SHAPIRO MICHAEL H.Chief Financial Officer
GrantCommon Stock 31,173 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-005303 · rdgdoc.xml · nonDerivative · entry 1

SHAPIRO MICHAEL H. · CIK 0001524881 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,933

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.